α1 Blocker

12 Drugs classified under this drug class

α1 Blocker. Alfuzosin (HCl) 10 mg.
TABS: 30. 1 tab aft. even. meal. Funct.
sympt. BPH when surg. delayed,
during severe sympt. adenoma espec.
in elderly.
TABS: 30. 1 tab dly aft. meal for 3-4
days, incl. 1 day aft. cath. removed.
Adjuv. tmt. catheter in acute urin. retent.
in BPH. Tmt. certain funct. sympts.
benign prost. hypertrophy.
C/I: Hypersens; orthostat. hypertens,
impair. liver funct.

α1 Blocker. Alfuzosin HCl 10 mg.
E.R. TABS: 30. 10 mg dly, immed. aft.
even. meal. Swallow whole with fluid.
Not to be crushed, chew. or divid.
Start ther. on day of insert. of urethral
cath. Tmt. 3-4 days, i.e. 2-3 days
during catheterizat. and 1 day follow.
removal.
Tmt. funct. sympts. BPH, espec. if surg.
delayed. Adjuv. tmt. to cathet. in acute
urinary retent. rel. to BPH.
C/I: Known hypersens., postural
hypotens., liver fail., severe kidney fail.,
combinat. with other alpha 1 blockers,
child.

5-α Reductase Inhibitor, α1 Blocker. Dutasteride 0.5 mg, Tamsulosin HCl 0.4 mg.
5-a Reductase Inhibitor/Alpha 1 Blocker. Dutasteride 0.5 mg, tamsulosin 0.4 mg.
CAPS: 30. 1 cap. dly. See lit.
Tmt. mod. to severe symp. BPH. Reduc. risk of acute urin. reten. (AUR) and surgery in pts. with mod. to severe sympt. of BPH.
C/I: Hyperses., women, child., adolesn., pts. with a hist. of orthost. hypotension, pts. with severe hepat. impair.

α1 Blocker. Phenoxybenzamine HCl 10 mg.
CAPS: 30. Pheochrom: 20-60 mg dly.,
Urin. retent: 10 mg 3 x dly. See lit.
Pheochromocytoma, urin. retent, BPH
and neurogen. bladder.

5-α Reductase Inhibitor, α1 Blocker. Dutasteride 0.5 mg, Tamsulosin HCl 0.4 mg.
CAPS: 30. 1 cap orally 30 mins. aft. same
meal each day.
Tmt. mod.-severe sympts. BPH. Reduct.
risk acute urin. retent. (AUR), surg. in pts.
with mod.-severe sympts. BPH.

α1 Blocker. Tamsulosin HCl 0.4 mg.
S.R. CAPS: 30. 1 cap dly aft. breakf. or
the 1st meal of the day.
Funct. sympts. BPH.